Showing results (501-510 of 519) with videos related to

Sort By:
Pageof 52
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|December 5, 2008
Genetic variants of Nogo-66 receptor with possible association to schizophrenia block myelin inhibition of axon growthStéphane Budel, Thihan Padukkavidana, Betty P Liu, et al.
European Radiology|June 27, 2023
Real-world efficacy and safety of TACE plus camrelizumab and apatinib in patients with HCC (CHANCE2211): a propensity score matching studyZhi-Cheng Jin, Bin-Yan Zhong, Jian-Jian Chen, et al.
Internal Medicine Journal|November 11, 2019
Characteristics of H7N9 avian influenza pneumonia: a retrospective analysis of 17 casesWen-Qing Yu, Ning-Fei Ji, Ming-Dong Ding, et al.
The Plant Cell|June 16, 2023
The protein phosphatase PC1 dephosphorylates and deactivates CatC to negatively regulate H2O2 homeostasis and salt tolerance in riceCong Liu, Jian-Zhong Lin, Yan Wang, et al.
The Journal of Clinical Investigation|March 17, 2026
Epigenetically controlled endothelial promyelocytic leukemia drives liver inflammation and fibrosisCan Gan, Enjiang Lai, Yang Tai, et al.
International Journal of Surgery (London, England)|December 9, 2025
Should transarterial chemoembolization be applied with systemic therapy for hepatocellular carcinoma with hepatic vein and/or inferior vena cava tumor thrombus (CHANCE2505)?: a multicenter studyLong-Wang Lin, Qian Chen, Hong-Tao Hu, et al.
Nucleic Acids Research|February 4, 2020
FAM46B is a prokaryotic-like cytoplasmic poly(A) polymerase essential in human embryonic stem cellsJia-Li Hu, He Liang, Hong Zhang, et al.
Academic Radiology|November 4, 2025
The METAL Score for Early Stratification of Radiological Response and Survival in Hepatocellular Carcinoma Treated with TACE and Immunotherapy CombinationsQian Chen, Long-Wang Lin, Zhi-Cheng Jin, et al.
Alimentary Pharmacology & Therapeutics|March 31, 2026
Camrelizumab and Apatinib With or Without Transarterial Chemoembolisation as First-Line Treatment for Advanced Hepatocellular Carcinoma (CHANCE2311)Rong Ding, Jin-Feng Bai, Zhi-Cheng Jin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 24, 2026
Transarterial Chemoembolization Combined With Camrelizumab and Rivoceranib for Unresectable Hepatocellular Carcinoma (CHANCE2005/CARES-005): A Randomized Phase II TrialHai-Dong Zhu, Wei-Jun Fan, Chang Zhao, et al.
Pageof 52